By using the innovative nanomaterials synthesized in the Biomedical Lab, our group has designed nano-size drug delivery systems with high tumor selectivity.

These materials bear active functional groups, which have been exploited to couple antibodies able to selectively recognize specific cancer cells. Our nano-systems have shown high efficacy inin vitrotests.


“Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells.”Clara Mattu, R. Pabari, Monica Boffito, Susanna Sartori, , Gianluca Ciardelli, Z. Ramtoola, European Journal of Pharmaceutics and Biopharmaceutics 2013, 85, 463-472.
“Therapeutic nanoparticles from novel multiblock engineered polyesterurethanes”C. Mattu, M. Boffito, S. Sartori, E. Ranzato, E. Bernardi, M. P. Sassi, A. M. Di Rienzo, G. Ciardelli. Journal of Nanoparticle Research 2012, 14.